Despite its reputation as the love drug, ecstasy has a violent back story. Host Kai Ryssdal talks with "Chemical Cowboys" author Lisa Sweetingham about the investigations that ended an ecstasy empire.
Swiss drug maker Roche is acquiring U.S. biotech giant Genentech in a $47 billion deal. Sam Eaton reports on the latest example of a pharmaceutical company buying out a competitor to boost its product line.
With budget-conscious universities cutting funding for high-tech research, potential breakthroughs that could stimulate the economy are being put on the back burner. Janet Babin reports.
Kai Ryssdal speaks with New York Times technology columnist David Pogue about how a new service called "Google Voice" could change the communication lines.
At least a dozen struggling life insurance institutions are following in banks' footsteps, hoping to get a bailout from the U.S. Treasury. Steve Henn reports.
As international finance leaders prepare to meet, there is disagreement over how to get the global economy back on track. As Stephen Beard reports, Germany is saying it's already spending a lot to stimulate its economy.
Disgraced investor Bernard Madoff pleaded guilty to masterminding a $50 billion Ponzi scheme, the largest in history. So where did all that money go? Bob Moon reports.